Subject: Regenerative medicine companies surge in 2019


It's official. Regenerative medicine (RM) companies are surging in 2019. 

As featured in the Global Regenerative Medicine (RM) Industry Database 2019, there are now 700+ companies developing regenerative medicine products for therapeutic use in humans. 

The rapid growth of RM companies is being driven by:
  • A high volume of clinical trials
  • Accelerated pathways for product approvals
  • World's first regulatory approvals of CAR-T therapies 
  • Increased interest among pharmaceutical companies in RM partnerships
  • Potential for regenerative medicine therapies to revolutionize healthcare
Because the number of companies can vary substantially depending on the definition of regenerative medicine that is applied (including included and excluded technologies), we define regenerative medicine companies as those pursuing therapeutic approaches that include:
While other organizations have applied a looser definition of regenerative medicine, our belief is that this targeted definition provides the most accurate coverage of the Regenerative Medicine (RM) Industry and its annual rate of growth.

One of the most recent additions to the database was Sana Biotechnology, a company formed only 7 days ago on January 4, 2019, to create and deliver engineered cells as medicines for patients. 

Unsurprisingly, it takes our analysts hours of research each week to uncover newly launched companies from across the globe. We also utilize translators to discover companies doing business in a diverse range of languages and crowd-source feedback from BioInformant's partners, clients, and followers.

The end result is the world’s only searchable, sortable database of RM companies that is continuously updated on a daily basis and available to the public.

This database was originally developed in-house for our own purposes, but we have had more and more clients requesting access to it.

For this reason, we are making it available – for a limited-time only. 

For the next 48 hours, you can claim the Global Regenerative Medicine Industry Database 2019 for 50% OFF (only $97) and receive FREE UPDATES for the next 12-months: 
Act soon, before it goes back in our vault where it belongs.

Be Great,
Cade



p.s. More than 150 clients have rated this database with 5.0 Stars (98.22%). Of course, your investment is backed by our Money Back Guarantee.

Have you claimed the database before? Reply to this email and we'll send you an updated 2019 version for FREE.





BIOINFORMANT | 800 Corporate Drive, Suite 301, Stafford, VA 22554, United States
You may unsubscribe or change your contact details at any time.

    This is an online snapshot of a newsletter created by the owner of BioInformant Worldwide, LLC | Stem Cell Industry Data (BioInformant.com, BIOINFORMANT | 800 Corporate Drive, Suite 301, 22554 Stafford) and sent via GetResponse on 2019-01-12. Report abuse